The Estée Lauder Companies Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

What’s Next for the Estée Lauder Cos. After Failed Merger Talks With Puig?

AI-generated analysis

📉 Merger talks with Puig ended due to valuation disagreements, pushing any new multibillion-dollar deals several years into the future.

🔧 CEO Stéphane de La Faverie is restructuring operations with an additional 9,000-10,000 job cuts approved by the end of the month.

💰 The company recorded $1.5 billion to $1.7 billion in restructuring charges to date as part of its Profit Recovery and Growth Plan.

📊 Net sales rose 5% to $3.7 billion, with fragrance growing 10% while skincare and makeup remained flat in the third quarter.

🏪 MAC Cosmetics entered Sephora U.S. for the first time but ranks fifth among makeup brands at the retailer.

💄 The Ordinary was the only Estée Lauder-owned brand to appear in the top 10 online sales during Sephora's Spring Savings Event.

🚪 Divestitures are active, with bids received for Too Faced, Smashbox, and Dr. Jart potentially closing within weeks.

🌍 The company lacks broad prestige fragrance presence in Europe and Latin America compared to competitors like L'Oréal.

🤝 Future M&A must be accretive to growth and profitability; Unilever is unlikely a near-term target due to its own deal with McCormick.

📉 Stock price has dropped over 20% year-to-date, trading at $84.64 compared to a peak market cap of over $133 billion in January 2022.

Bullish Signals
  • The company successfully increased overall net sales by 5% to $3.7 billion despite a challenging macro environment.
  • Fragrance segment grew by 10%, serving as the primary driver for recent revenue beats and margin recovery.
  • MAC Cosmetics achieved significant market share growth in lip gloss (250 basis points) following its entry into Sephora U.S.
  • The 'Beauty Reimagined' strategy aims to restore sustainable sales growth and achieve double-digit adjusted operating margins.
  • Active divestiture of non-core brands like Too Faced and Smashbox could free up cash for future strategic acquisitions.
Risk Factors
  • Skin care, makeup, and hair care sales were flat in the third quarter of fiscal 2026, indicating stagnation in core categories.
  • North America net sales grew only 1% in the most recent quarter, highlighting a lack of momentum in the largest market.
  • The company faces intense competition from L'Oréal, which recently entered a joint venture with Kering to strengthen its position.
  • MAC Cosmetics ranks as the number-five makeup brand at Sephora U.S., indicating it has not yet secured dominant shelf space.
  • Total stock price has declined significantly, trading around $84.64 after peaking above $370 in January 2022.
  • The company lacks a broad portfolio of prestige fragrances outside of Europe and Latin America compared to major rivals.
Full Analysis
Following the termination of merger talks with Puig, the Estée Lauder Cos. is pivoting its strategy toward divestitures, investor relations repair, and a renewed focus on its 'Beauty Reimagined' program. CEO Stéphane de La Faverie confirmed that the deal failed primarily due to valuation disagreements, noting that future M&A must be accretive to growth and profitability. The company currently trades around $84.64, having fallen significantly from its 2022 peak, with analysts suggesting a multi-year horizon for any new multibillion-dollar combinations. To address stagnation in North America and competition from L'Oréal, Estée Lauder is executing a restructuring plan that includes an additional reduction of 9,000 to 10,000 positions by the end of fiscal 2026. The company has recorded $1.5 billion to $1.7 billion in restructuring charges to date and is actively assessing its portfolio for potential sales, with Too Faced, Smashbox, and Dr. Jart currently under consideration. While MAC Cosmetics recently expanded into Sephora U.S., the brand still faces challenges in securing top-tier shelf space compared to competitors. Financially, the company reported a 5% overall net sales increase to $3.7 billion for the quarter, driven largely by fragrance growth of 10%, while skincare and makeup remained flat. CEO de La Faverie emphasized that while the portfolio includes luxury niche brands like Le Labo and Tom Ford, the company lacks broad presence in prestige fragrances outside of Europe and Latin America. Consequently, the leadership team remains price-conscious regarding acquisitions, prioritizing shareholder value over strategic fit alone.